Key barriers to medication adherence in survivors of strokes and transient ischemic attacks

Journal of General Internal Medicine

Volumn 28, Issue 5, 2013, Pages 675-682

  Kronish, Ian M ^a   Diefenbach, Michael A ^b   Edmondson, Donald E ^a   Phillips, L Alison ^c   Fei, Kezhen ^b   Horowitz, Carol R ^b  

^a NewYork Presbyterian Hospital   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

Barriers; Medication adherence; Stroke; Transient ischemic attack

Indexed keywords

ACADEMIC ACHIEVEMENT; ADULT; ARTICLE; ATTITUDE TO ILLNESS; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DOCTOR PATIENT RELATION; DRUG COST; EIGHT ITEM MORISKY MEDICATION ADHERENCE QUESTIONNAIRE; ETHNIC DIFFERENCE; EXPLORATORY RESEARCH; FEMALE; HEALTH CARE ACCESS; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HUMAN; INTERPERSONAL COMMUNICATION; KNOWLEDGE; LANGUAGE; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; MINORITY GROUP; PATIENT CARE; PATIENT WORRY; PHYSICIAN; QUESTIONNAIRE; RACE DIFFERENCE; SELF REPORT; SOCIAL DISCRIMINATION; SURVIVOR; TRANSIENT ISCHEMIC ATTACK; TRUST; UNITED STATES; AGED; ATTITUDE TO HEALTH; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HUMAN RELATION; ISCHEMIC ATTACK, TRANSIENT; PSYCHOLOGY; PSYCHOMETRY; SECONDARY PREVENTION; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; STROKE; PSYCHOLOGICAL ASPECT; RECURRENT DISEASE; STATISTICS;

ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SERVICES ACCESSIBILITY; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MEDICALLY UNDERSERVED AREA; MEDICATION ADHERENCE; MIDDLE AGED; NEW YORK CITY; PROFESSIONAL-PATIENT RELATIONS; PSYCHOMETRICS; SECONDARY PREVENTION; SOCIOECONOMIC FACTORS; STROKE; SURVIVORS; RECURRENCE;

EID: 84891398420     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-012-2308-x     Document Type: Article

References (44)

1. Heron M, Hoyert DL, Murphy SL, Xu J, Kochanek KD, Tejada-Vera B. Deaths: Final data for 2006. Natl Vital Stat Rep. 2009;57:1-134.
2. Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, Goldstein LB, Gorelick P, Halperin J, Harbaugh R, Johnston SC, Katzan I, Kelly-Hayes M, Kenton EJ, Marks M, Schwamm LH, Tomsick T. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: A statement for healthcare professionals from the american heart association/american stroke association council on stroke: Co-sponsored by the council on cardiovascular radiology and intervention: The American Academy of Neurology affirms the value of this guideline. Circulation. 2006;113:e409-449.
3. Rothwell PM, Algra A, Amarenco P. Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic stroke. Lancet. 2011;377:1681-1692.
4. Bushnell CD, Zimmer LO, Pan W, Olson DM, Zhao X, Meteleva T, Schwamm L, Ovbiagele B, Williams L, Labresh KA, Peterson ED. Persistence with stroke prevention medications 3 months after hospitalization. Arch Neurol. 2010;67:1456-1463.
5. Khan NA, Yun L, Humphries K, Kapral M. Antihypertensive drug use and adherence after stroke: Are there sex differences Stroke. 2010;41:1445-1449.
6. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487-497.
7. Mann DM, Woodward M, Muntner P, Falzon L, Kronish I. Predictors of nonadherence to statins: A systematic review and meta-analysis. Ann Pharmacother. 2010;44:1410-1421.
8. O'Carroll R, Whittaker J, Hamilton B, Johnston M, Sudlow C, Dennis M. Predictors of adherence to secondary preventive medication in stroke patients. Ann Behav Med. 2011;41:383-390.
9. Chambers JA, O'Carroll RE, Hamilton B, Whittaker J, Johnston M, Sudlow C, Dennis M. Adherence to medication in stroke survivors: A qualitative comparison of low and high adherers. Br J Health Psychol. 2011;16:592-609.
10. Cox AM, McKevitt C, Rudd AG, Wolfe CD. Socioeconomic status and stroke. Lancet Neurol. 2006;5:181-188.
11. Stansbury JP, Jia H, Williams LS, Vogel WB, Duncan PW. Ethnic disparities in stroke: Epidemiology, acute care, and post-acute outcomes. Stroke. 2005;36:374-386.
12. Sacco RL, Boden-Albala B, Abel G, Lin IF, Elkind M, Hauser WA, Paik MC, Shea S. Race-ethnic disparities in the impact of stroke risk factors: The northern Manhattan stroke study. Stroke. 2001;32:1725-1731.
13. Leventhalm H, Benyamini Y, Brownlee S, et al. Illness Perceptions: Theoretical Foundations. In: Petrie KJ, Weinman J, eds. Perceptions of Health and Illness. Amsterdam: Harwood; 1997:19-45.
14. Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;47:555-567.
15. Goldfinger JZ, Kronish IM, Fei K, Graciani A, Rosenfeld P, Lorig K, Horowitz CR. Peer education for secondary stroke prevention in innercity minorities: Design and methods of the prevent recurrence of all inner-city strokes through education randomized controlled trial. Contemp Clin Trials. 2012
16. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10:348-354.
17. Krousel-Wood M, Islam T, Webber LS, Re RN, Morisky DE, Muntner P. New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care. 2009;15:59-66.
18. Holt EW, Muntner P, Joyce C, Morisky DE, Webber LS, Krousel-Wood M. Life events, coping, and antihypertensive medication adherence among older adults: The cohort study of medication adherence among older adults. Am J Epidemiol. 2012;176(Suppl 7):S64-71.
19. Svarstad BL, Chewning BA, Sleath BL, Claesson C. The brief medication questionnaire: A tool for screening patient adherence and barriers to adherence. Patient Educ Couns. 1999;37:113-124.
20. Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SC, Halperin JL, Johnston SC, Katzan I, Kernan WN, Mitchell PH, Ovbiagele B, Palesch YY, Sacco RL, Schwamm LH, Wassertheil- Smoller S, Turan TN, Wentworth D. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:227-276.
21. Safran DG, Kosinski M, Tarlov AR, Rogers WH, Taira DH, Lieberman N, Ware JE. The primary care assessment survey: Tests of data quality and measurement performance. Med Care. 1998;36:728-739.
22. Stewart AL, Napoles-Springer A, Perez-Stable EJ. Interpersonal processes of care in diverse populations. Milbank Q. 1999;77:305-339. 274.
23. Bindman AB, Grumbach K, Osmond D, Komaromy M, Vranizan K, Lurie N, Billings J, Stewart A. Preventable hospitalizations and access to health care. JAMA. 1995;274:305-311.
24. MaddenJM,GravesAJ, ZhangF,AdamsAS, Briesacher BA, Ross-DegnanD, Gurwitz JH, Pierre-Jacques M, Safran DG, Adler GS, Soumerai SB. Costrelated medication nonadherence and spending on basic needs following implementation of medicare part d. JAMA. 2008;299:1922-1928.
25. Banks JL, Marotta CA. Outcomes validity and reliability of the modified rankin scale: Implications for stroke clinical trials: A literature review and synthesis. Stroke. 2007;38:1091-1096.
26. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis. 1987;40:373-383.
27. Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;47:555-567.
28. Sud A, Kline-Rogers EM, Eagle KA, Fang J, Armstrong DF, Rangarajan K, Otten RF, Stafkey-Mailey DR, Taylor SD, Erickson SR. Adherence to medications by patients after acute coronary syndromes. Ann Pharmacother. 2005;39:1792-1797.
29. Phatak HM, Thomas J 3rd. Relationships between beliefs about medications and nonadherence to prescribed chronic medications. Ann Pharmacother. 2006;40:1737-1742.
30. Bird ST, Bogart LM, Delahanty DL. Health-related correlates of perceived discrimination in hiv care. AIDS Patient Care STDS. 2004;18:19-26.
31. Boarts JM, Bogart LM, Tabak MA, Armelie AP, Delahanty DL. Relationship of race-, sexual orientation-, and hiv-related discrimination with adherence to hiv treatment: A pilot study. J Behav Med. 2008;31:445-451.
32. Casagrande SS, Gary TL, LaVeist TA, Gaskin DJ, Cooper LA. Perceived discrimination and adherence to medical care in a racially integrated community. J Gen Intern Med. 2007;22:389-395.
33. Dailey AB, Kasl SV, Holford TR, Jones BA. Perceived racial discrimination and nonadherence to screening mammography guidelines: Results from the race differences in the screening mammography process study. Am J Epidemiol. 2007;165:1287-1295.
34. Kronish IM, Leventhal H, Horowitz CR. Understanding minority patients' beliefs about hypertension to reduce gaps in communication between patients and clinicians. J Clin Hypertens (Greenwich). 2012;14:38-44.
35. Johnson RL, Saha S, Arbelaez JJ, Beach MC, Cooper LA. Racial and ethnic differences in patient perceptions of bias and cultural competence in health care. J Gen Intern Med. 2004;19:101-110.
36. Piette JD, Heisler M, Horne R, Caleb Alexander G. A conceptually based approach to understanding chronically ill patients' responses to medication cost pressures. Soc Sci Med. 2006;62:846-857.
37. Choudhry NK, Avorn J, Glynn RJ, Antman EM, Schneeweiss S, Toscano M, Reisman L, Fernandes J, Spettell C, Lee JL, Levin R, Brennan T, Shrank WH. Post-myocardial infarction free Rx event and economic evaluation (MI FREEE) trial. Full coverage for preventive medications after myocardial infarction. N Engl J Med. 2011;365:2088- 2097.
38. Gehi AK, Ali S, Na B, Whooley MA. Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: The heart and soul study. Arch Intern Med. 2007;167:1798-1803.
39. Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA. 2007;297:177-186.
40. Shi L, Liu J, Koleva Y, Fonseca V, Kalsekar A, Pawaskar M. Concordance of adherence measurement using self-reported adherence questionnaires and medication monitoring devices. PharmacoEconomics. 2010;28:1097-1107.
41. Zhang Y, Baik SH, Chang CC, Kaplan CM, Lave Jr. Disability, race/ethnicity, and medication adherence among medicare myocardial infarction survivors. Am Heart J. 2012;164:425-433. e424.
42. Schoenthaler A, Chaplin WF, Allegrante JP, Fernandez S, Diaz- Gloster M, Tobin JN, Ogedegbe G. Provider communication effects medication adherence in hypertensive African Americans. Patient Educ Couns. 2009;75:185-191.
43. Cutrona SL, Choudhry NK, Stedman M, Servi A, Liberman JN, Brennan T, Fischer MA, Brookhart MA, Shrank WH. Physician effectiveness in interventions to improve cardiovascular medication adherence: A systematic review. J Gen Intern Med. 2010;25:1090-1096.
44. Ogedegbe G, Chaplin W, Schoenthaler A, Statman D, Berger D, Richardson T, Phillips E, Spencer J, Allegrante JP. A practice-based trial of motivational interviewing and adherence in hypertensive African Americans. Am J Hypertens. 2008;21:1137-1143.